In recent years, there has been a growing interest in the potential therapeutic effects of psilocybin, a naturally occurring psychedelic compound found in certain mushrooms, particularly those belonging to the genus Psilocybe. One area of significant exploration is the use of psilocybin in treating treatment-resistant depression (TRD), a condition that poses a significant challenge for conventional antidepressant treatments.
